子痫前期分娩胎盘形态学研究:印度和巴基斯坦前瞻性观察研究(PURPOSe)结果
PURPOSe研究在印度和巴基斯坦两个中心五家三级医院比较子痫前期与非子痫前期孕妇的胎盘表现,子痫前期组母体血管灌注不良占57.3%高于非子痫前期组37.1%(p<0.0001),炎症病变则较少见(17.1% vs 23.6%,p=0.001)。
要点
- 子痫前期胎盘以母体血管灌注不良最常见(57.3% vs 37.1%,p<0.0001)。
- 子痫前期胎盘组织学异常率61.3%,高于非子痫前期45.0%(p<0.0001)。
- 子痫前期胎盘炎症病变较少(17.1% vs 23.6%,p=0.001)。
核心结论
- 子痫前期孕妇的胎盘病变以母体血管灌注不良最为常见,炎症病变在子痫前期孕妇中较少见。
研究设计与样本
- PURPOSe研究为前瞻性观察研究,纳入印度和巴基斯坦两个中心五家三级医院(印度三家、巴基斯坦两家)的孕妇,包括死胎、早产和足月对照,胎盘采用Amsterdam标准评估。
- 共733例子痫前期孕妇和2334例既无高血压也无蛋白尿的孕妇纳入胎盘组织学分析。
主要发现
- 子痫前期组母体血管灌注不良占57.3%,非子痫前期组占37.1%(p<0.0001);胎儿血管灌注不良在子痫前期组17.1%与非子痫前期组14.8%间无显著差异(p=0.6118)。
- 子痫前期组胎盘组织学异常占61.3%,非子痫前期组占45.0%(p<0.0001)。
- 死胎合并子痫前期者母体血管灌注不良占79.9%,无子痫前期死胎者占51.8%;早产活产合并子痫前期者占49.7%,无子痫前期早产活产者占33.8%;无子痫前期足月者占16.7%。
- 子痫前期组全部炎症病变占17.1%,非子痫前期组占23.6%(p=0.001);绒毛膜羊膜炎在子痫前期组占16.1%,非子痫前期组占21.9%(p=0.004);脐带炎在子痫前期组占1.5%,非子痫前期组占5.1%(p=0.0004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare placental findings in women with and without pre-eclampsia. DESIGN: The PURPOSe study included women with stillbirths, women with preterm births and women at term as controls. The placenta of each case was evaluated using the Amsterdam criteria. SETTING: Two sites and five tertiary care hospitals of south Asia (Three in India and two in Pakistan). POPULATION: Pregnancies in India and Pakistan with placental histology including women with documented hypertension and documented proteinuria and women with neither hypertension nor proteinuria. METHODS: We compared the placental findings of the two groups using the Amsterdam criteria and further evaluated the placental findings in women with and without pre-eclampsia who had a stillbirth, preterm live birth, or term live birth (control). MAIN OUTCOME MEASURES: The main outcome measures were the frequency of maternal and fetal vascular malperfusion and the frequency of placental inflammation and its components, chorioamnionitis, funisitis, villitis and intervillitis in women with and without pre-eclampsia. RESULTS: A total of 733 women had pre-eclampsia and 2334 women had neither hypertension nor proteinuria. In the placentas of women with pre-eclampsia, 57.3% had maternal vascular malperfusion compared with 37.1% in women without pre-eclampsia (p < 0.0001). There was not a significant difference in the prevalence of fetal vascular hypertension between mothers with (17.1%) and without (14.8%, p = 0.6118) pre-eclampsia. When placentas were classified as 'histologically normal' or not, 61.3% of those from pre-eclamptic pregnancies were classified as abnormal, whereas if there was no pre-eclampsia, only 45.0% were classified as histologically abnormal (p < 0.0001). We also considered rates of placental maternal vascular malperfusion in women with and without pre-eclampsia with stillbirth, preterm neonatal death, and term live birth. In women at term with no pre-eclampsia, 16.7% of the placentas had features of maternal vascular malperfusion. This occurred in 79.9% of women with stillbirths with pre-eclampsia compared with 51.8% of those without pre-eclampsia. Maternal vascular malperfusion was present in 49.7% of preterm live births with pre-eclampsia compared with 33.8% without pre-eclampsia. We also evaluated the inflammatory lesions by whether the mother had or did not have pre-eclampsia. When all inflammatory lesions were considered, women with pre-eclampsia had significantly fewer inflammatory lesions than those women without pre-eclampsia (17.1% versus 23.6% p = 0.001). Each of the specific inflammatory lesions was less common in placentas of women with pre-eclampsia than those with chorioamnionitis (16.1% versus 21.9%, p = 0.004) and funisitis (1.5% versus. 5.1%, p = 0.0004). CONCLUSIONS: Of placental lesions in women with pre-eclampsia, maternal vascular malperfusion was the most common. Inflammatory lesions were less common in women with pre-eclampsia.
引用
- Yogeshkumar S, Dhananjay S, Gowdar S, et al. Morphological study of the placenta in deliveries with pre-eclampsia: Results from a prospective, observational study in India and Pakistan (PURPOSe). BJOG. 2023. PMID: 37530629. doi:10.1111/1471-0528.17617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。